- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.77 Å
- Oligo State
- homo-trimer
- Ligands
- 21 x SO4: SULFATE ION(Non-functional Binders)
SO4.1: 5 residues within 4Å:- Chain A: F.44, E.45, N.46
- Chain C: R.82, R.130
Ligand excluded by PLIPSO4.2: 5 residues within 4Å:- Chain A: K.69, L.167, G.169, H.170, N.171
Ligand excluded by PLIPSO4.3: 7 residues within 4Å:- Chain A: V.84, P.85, R.130, G.131, F.132, E.257, A.260
Ligand excluded by PLIPSO4.4: 4 residues within 4Å:- Chain A: L.109, L.218, N.219, R.224
Ligand excluded by PLIPSO4.5: 2 residues within 4Å:- Chain A: R.82, R.83
Ligand excluded by PLIPSO4.6: 5 residues within 4Å:- Chain A: L.147, Y.148, S.149, T.150, Q.155
Ligand excluded by PLIPSO4.7: 4 residues within 4Å:- Chain A: N.80, Q.160, S.163, I.164
Ligand excluded by PLIPSO4.12: 5 residues within 4Å:- Chain A: R.82, R.130
- Chain B: F.44, E.45, N.46
Ligand excluded by PLIPSO4.13: 5 residues within 4Å:- Chain B: K.69, L.167, G.169, H.170, N.171
Ligand excluded by PLIPSO4.14: 7 residues within 4Å:- Chain B: V.84, P.85, R.130, G.131, F.132, E.257, A.260
Ligand excluded by PLIPSO4.15: 4 residues within 4Å:- Chain B: L.109, L.218, N.219, R.224
Ligand excluded by PLIPSO4.16: 2 residues within 4Å:- Chain B: R.82, R.83
Ligand excluded by PLIPSO4.17: 5 residues within 4Å:- Chain B: L.147, Y.148, S.149, T.150, Q.155
Ligand excluded by PLIPSO4.18: 4 residues within 4Å:- Chain B: N.80, Q.160, S.163, I.164
Ligand excluded by PLIPSO4.23: 5 residues within 4Å:- Chain B: R.82, R.130
- Chain C: F.44, E.45, N.46
Ligand excluded by PLIPSO4.24: 5 residues within 4Å:- Chain C: K.69, L.167, G.169, H.170, N.171
Ligand excluded by PLIPSO4.25: 7 residues within 4Å:- Chain C: V.84, P.85, R.130, G.131, F.132, E.257, A.260
Ligand excluded by PLIPSO4.26: 4 residues within 4Å:- Chain C: L.109, L.218, N.219, R.224
Ligand excluded by PLIPSO4.27: 2 residues within 4Å:- Chain C: R.82, R.83
Ligand excluded by PLIPSO4.28: 5 residues within 4Å:- Chain C: L.147, Y.148, S.149, T.150, Q.155
Ligand excluded by PLIPSO4.29: 4 residues within 4Å:- Chain C: N.80, Q.160, S.163, I.164
Ligand excluded by PLIP- 3 x GOL: GLYCEROL(Non-functional Binders)
GOL.8: 2 residues within 4Å:- Chain A: S.222, R.226
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:R.226, A:R.226
GOL.19: 2 residues within 4Å:- Chain B: S.222, R.226
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:R.226, B:R.226
GOL.30: 2 residues within 4Å:- Chain C: S.222, R.226
2 PLIP interactions:2 interactions with chain C- Hydrogen bonds: C:R.226, C:R.226
- 3 x 35E: [1-(3-{[1-(quinolin-2-yl)azetidin-3-yl]oxy}pyrazin-2-yl)piperidin-4-yl]methanol(Non-covalent)
35E.9: 17 residues within 4Å:- Chain A: Y.86, L.197, L.237, S.239, V.240, T.247, A.251, I.254, Y.255, F.258, P.274, M.275, E.283, V.284, G.287, Q.288, F.291
4 PLIP interactions:4 interactions with chain A- Hydrophobic interactions: A:V.240, A:Y.255, A:M.275
- Hydrogen bonds: A:T.247
35E.20: 17 residues within 4Å:- Chain B: Y.86, L.197, L.237, S.239, V.240, T.247, A.251, I.254, Y.255, F.258, P.274, M.275, E.283, V.284, G.287, Q.288, F.291
5 PLIP interactions:5 interactions with chain B- Hydrophobic interactions: B:V.240, B:Y.255, B:M.275
- Hydrogen bonds: B:T.247, B:Y.255
35E.31: 17 residues within 4Å:- Chain C: Y.86, L.197, L.237, S.239, V.240, T.247, A.251, I.254, Y.255, F.258, P.274, M.275, E.283, V.284, G.287, Q.288, F.291
4 PLIP interactions:4 interactions with chain C- Hydrophobic interactions: C:V.240, C:Y.255, C:M.275
- Hydrogen bonds: C:T.247
- 6 x ZN: ZINC ION(Non-covalent)
ZN.10: 3 residues within 4Å:- Chain A: D.126, H.157
- Ligands: ZN.11
5 PLIP interactions:2 interactions with chain A, 3 Ligand-Water interactions- Metal complexes: A:D.126, A:D.126, H2O.1, H2O.1, H2O.1
ZN.11: 5 residues within 4Å:- Chain A: H.91, H.125, D.126, D.236
- Ligands: ZN.10
5 PLIP interactions:4 interactions with chain A, 1 Ligand-Water interactions- Metal complexes: A:H.91, A:H.125, A:D.126, A:D.236, H2O.1
ZN.21: 3 residues within 4Å:- Chain B: D.126, H.157
- Ligands: ZN.22
5 PLIP interactions:2 interactions with chain B, 3 Ligand-Water interactions- Metal complexes: B:D.126, B:D.126, H2O.2, H2O.2, H2O.2
ZN.22: 5 residues within 4Å:- Chain B: H.91, H.125, D.126, D.236
- Ligands: ZN.21
5 PLIP interactions:4 interactions with chain B, 1 Ligand-Water interactions- Metal complexes: B:H.91, B:H.125, B:D.126, B:D.236, H2O.2
ZN.32: 3 residues within 4Å:- Chain C: D.126, H.157
- Ligands: ZN.33
5 PLIP interactions:2 interactions with chain C, 3 Ligand-Water interactions- Metal complexes: C:D.126, C:D.126, H2O.3, H2O.3, H2O.4
ZN.33: 5 residues within 4Å:- Chain C: H.91, H.125, D.126, D.236
- Ligands: ZN.32
5 PLIP interactions:4 interactions with chain C, 1 Ligand-Water interactions- Metal complexes: C:H.91, C:H.125, C:D.126, C:D.236, H2O.3
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Rzasa, R.M. et al., Synthesis and preliminary biological evaluation of potent and selective 2-(3-alkoxy-1-azetidinyl) quinolines as novel PDE10A inhibitors with improved solubility. Bioorg.Med.Chem. (2014)
- Release Date
- 2014-12-17
- Peptides
- cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.77 Å
- Oligo State
- homo-trimer
- Ligands
- 21 x SO4: SULFATE ION(Non-functional Binders)
- 3 x GOL: GLYCEROL(Non-functional Binders)
- 3 x 35E: [1-(3-{[1-(quinolin-2-yl)azetidin-3-yl]oxy}pyrazin-2-yl)piperidin-4-yl]methanol(Non-covalent)
- 6 x ZN: ZINC ION(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Rzasa, R.M. et al., Synthesis and preliminary biological evaluation of potent and selective 2-(3-alkoxy-1-azetidinyl) quinolines as novel PDE10A inhibitors with improved solubility. Bioorg.Med.Chem. (2014)
- Release Date
- 2014-12-17
- Peptides
- cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
A